Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients. 2023

Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
Department of Nephrology, Jiangmen Central Hospital, Jiangmen, China.

Remnant cholesterol (RC) adversely contributes to cardiovascular disease (CVD) and overall survival in various diseases. However, its role in CVD outcomes and all-cause mortality in patients undergoing peritoneal dialysis (PD) is limited. Therefore, we aimed to investigate the association between RC and all-cause and CVD mortality in patients undergoing PD. Based on lipid profiles recorded using standard laboratory procedures, fasting RC levels were calculated in 2710 incident patients undergoing PD who were enrolled between January 2006 and December 2017 and followed up until December 2018. Patients were divided into four groups according to the quartile distribution of baseline RC levels (Q1: <0.40 mmol/L, Q2: 0.40 to <0.64 mmol/L, Q3: 0.64 to <1.03 mmol/L, and Q4: ≥1.03 mmol/L). Associations between RC and CVD and all-cause mortality were evaluated using multivariable Cox models. During the median follow-up period of 35.4 months (interquartile range, 20.9-57.2 months), 820 deaths were recorded, of which 438 were CVD-related. Smoothing plots showed non-linear relationships between RC and adverse outcomes. The risks of all-cause and CVD mortality increased progressively through the quartiles (log-rank, p < 0.001). Using adjusted proportional hazard models, a comparison of the highest (Q4) to lowest (Q1) quartiles revealed significant increases in the hazard ratio (HR) for all-cause mortality (HR 1.95 [95% confidence interval (CI), 1.51-2.51]) and CVD mortality risk (HR 2.60 [95% CI, 1.80-3.75]). An increased RC level was independently associated with all-cause and CVD mortality in patients undergoing PD, suggesting that RC was important clinically and required further research.

UI MeSH Term Description Entries
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard

Related Publications

Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2023, Renal failure,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
November 2023, BMC cardiovascular disorders,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
November 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2023, Journal of clinical lipidology,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
March 2020, Scientific reports,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2019, PloS one,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2013, PloS one,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
February 2009, JAMA,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2018, Kidney & blood pressure research,
Jihong Deng, and Ruiying Tang, and Jiexin Chen, and Qian Zhou, and Xiaojiang Zhan, and Haibo Long, and Fenfen Peng, and Xiaoyang Wang, and Yueqiang Wen, and Xiaoran Feng, and Ning Su, and Xingming Tang, and Na Tian, and Xianfeng Wu, and Qingdong Xu
January 2024, Kidney & blood pressure research,
Copied contents to your clipboard!